A comparison of gene repair strategies in cell culture using a lacZ reporter system
Open Access
- 8 August 2003
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (18) , 1584-1591
Abstract
Synthetic oligonucleotides and DNA fragments of less than 1 kilobase (kb) have been shown to cause site-specific genetic alterations in mammalian cells in culture and in vivo. We have used a lacZ reporter gene system to compare the efficiency of episomal and chromosomal gene repair in human embryonic kidney epithelial cells (HEK293), Chinese Hamster Ovary fibroblasts (CHOK1), human bronchial epithelial cells (16HBE), and mouse embryonic stem (ES) cells. The lacZ gene contains a G to A nucleotide change, (Glu to Lys mutation) that abrogates β-galactosidase activity. We compared the efficiency of different gene repair methods to correct this mutation and restore β-galactosidase activity. We evaluated PCR-generated double-stranded DNA fragments of 0.52–1.9 kb, single-stranded DNA oligonucleotides of 20, 35, or 80 bases containing internal phosphorothioate links, and a 68 base RNA:DNA oligonucleotide. All of the oligonucleotides and DNA fragments showed some gene repair ability with an episomal plasmid. Short DNA fragments of 0.52 kb or greater gave the highest frequencies of episomal gene repair while single-stranded DNA oligonucleotides gave the highest frequency of chromosomal repair. In the context of a chromosomal target, antisense DNA oligonucleotides gave 5-fold higher frequencies of gene repair than their sense counterparts. The RNA:DNA chimeric oligonucleotide gave little or no gene repair on either a chromosomal or episomal target.Keywords
This publication has 18 references indexed in Scilit:
- Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHRGene Therapy, 2001
- In Vivo and in Vitro Correction of the mdx Dystrophin Gene Nonsense Mutation by Short-Fragment Homologous ReplacementHuman Gene Therapy, 2001
- Targeted gene correction by small single-stranded oligonucleotides in mammalian cellsGene Therapy, 2001
- Targeted Correction of a Defective Selectable Marker Gene in Human Epithelial Cells by Small DNA FragmentsMolecular Therapy, 2001
- Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotideNature Biotechnology, 2000
- Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler–Najjar syndrome type I with a chimeric oligonucleotideProceedings of the National Academy of Sciences, 1999
- Nucleotide Exchange in Genomic DNA of Rat Hepatocytes Using RNA/DNA OligonucleotidesJournal of Biological Chemistry, 1999
- Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotideNature Biotechnology, 1998
- Failure to Achieve Gene Conversion with Chimeric Circular Oligonucleotides: Potentially Misleading PCR Artifacts ObservedAntisense and Nucleic Acid Drug Development, 1998
- Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragmentsHuman Molecular Genetics, 1998